Clinical Trials Browser

Bone Diseases, Metabolic × Zoledronic Acid × Breast × Clear all

NCT01623908 2021-06-22

BLAZE

Phase NA Terminated

Bone Diseases, Metabolic, Breast Neoplasms

NCT00171340 2012-04-16

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

Phase 3 Completed

1,065 enrolled 10 charts

Bone Diseases, Metabolic, Breast Neoplasms